Skip to main content
An official website of the United States government
Email

Equity and Representation in Global Oncology Research

June 22, 2022 | 12:30 PM – 1:30 PM

Webex

Add to Outlook Calendar

The Division of Cancer Epidemiology and Genetics (DCEG) Fellows Cancer Health Disparities Group and the NCI Global Health Interest Group will co-host this seminar to discuss equity and representation in global oncology research. Registration is not required. 

Join the seminar

Picture of Dr. Temidayo Fadelu MD MPH

Temidayo Fadelu, M.D., M.P.H.

Instructor of Medicine, Harvard Medical School

Physician, Medical Oncology, Dana-Farber Cancer Institute

Temidayo Fadelu, M.D., M.P.H., will present on equity and representation in global oncology research. Dr. Fadelu's clinical and research interests are in breast cancer, health services research, and global oncology implementation. Originally from Nigeria, Dr. Fadelu moved to the US for his undergraduate education at Baylor University. He earned his medical degree from Yale University School of Medicine and completed his training in internal medicine at the Hospital of the University of Pennsylvania. He then moved to Rwanda to serve as clinical and programmatic implementation lead for an oncology program based at Butaro Cancer Center of Excellence in rural northern Rwanda (2013-2015). He coordinated several major initiatives including the implementation of pathology and palliative care services as well as an electronic medical records platform to facilitate evaluation of patient outcomes. He moved back to the US to complete his fellowship training in medical oncology at Dana-Farber Cancer Institute, during which he also completed a Masters in Public Health at the Harvard T.H. Chan School of Public Health. He remains at Dana-Farber as a member of their Center for Global Cancer Medicine, where he is engaged in implementation research projects in Rwanda and Haiti to address global inequities in breast cancer care and outcomes. He has received research funding from Conquer Cancer Foundation, Breast Cancer Research Foundation, Robert Wood Johnson Foundation, and as a trainee on a KL2 Mentored Career Development Award. 

Email